Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

ADC Therapeutics (ADCT) Return on Invested Capital (2023 - 2026)

ADC Therapeutics has reported Return on Invested Capital over the past 4 years, most recently at 0.02% for Q1 2026.

  • Quarterly results put Return on Invested Capital at 0.02% for Q1 2026, changed 0.0% from a year ago — trailing twelve months through Mar 2026 was 0.02% (changed 0.0% YoY), and the annual figure for FY2022 was 0.0%, up 1.0%.
  • Return on Invested Capital reached 0.02% in Q1 2026 per ADCT's latest filing, up from 0.01% in the prior quarter.
  • Across five years, Return on Invested Capital topped out at 1.81% in Q3 2023 and bottomed at 17.43% in Q2 2023.
  • Median Return on Invested Capital over the past 4 years was 0.01% (2025), compared with a mean of 1.73%.
  • Peak annual rise in Return on Invested Capital hit 1668bps in 2024, while the deepest fall reached -176bps in 2024.
  • Over 4 years, Return on Invested Capital stood at 1.81% in 2023, then plummeted by -97bps to 0.05% in 2024, then tumbled by -70bps to 0.01% in 2025, then grew by 14bps to 0.02% in 2026.
  • Business Quant data shows Return on Invested Capital for ADCT at 0.02% in Q1 2026, 0.01% in Q3 2025, and 0.01% in Q2 2025.